<DOC>
<DOCNO>
EP-0002927
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
C07D-499/42 C07D-499/00 <main>C07D-499/42</main> A61K-31/43 
</IPC-CLASSIFICATIONS>
<TITLE>
penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
pfizerus<sep>pfizer inc.<sep>pfizer inc.235 east 42nd streetnew york, n.y. 10017us<sep>pfizer inc.<sep>
</APPLICANT>
<INVENTOR>
barth wayne ernest<sep>barth, wayne ernest<sep>barth, wayne ernest40 monticello driveeast lyme connecticutus<sep>barth, wayne ernest<sep>barth, wayne ernest40 monticello driveeast lyme connecticutus<sep>
</INVENTOR>
<ABSTRACT>
6-aminopenicillanic acid 1,1-dioxide, esters thereof  readily hydrolyzable in vivo, and the pharmaceutically-acceptable  salts of these compounds, are useful for enhancing  the effectiveness of certain β-lactam antibiotics  against certain β-lactamase producing bacteria.  derivatives  of 6-aminopenicillanic acid 1,1-dioxide protected by a conventional  carboxy protecting group are useful intermediates  to 6-aminopenicillanic acid 1,1-dioxide and esters thereof  readily hydrolyzable in vivo.  processes for their preparation  and pharmaceutical compositions are described.  
</ABSTRACT>
</TEXT>
</DOC>
